BioLife Solutions Inc. logo

BioLife Solutions Inc.

BLFS | NASDAQ
Chart Builder DCF Calculator
$38.12
+$0.94 (+2.53%)
Sep 22, 2026, 2:03 PM ET · Market open

Company Profile

BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing. Key products include proprietary biopreservation media, such as HypoThermosol FRS and CryoStor, which are engineered to minimize delayed cell damage and death typically associated with preservation. Complementing these are the ThawSTAR products, an automated line of devices for thawing vials and cryobags, designed to precisely manage the heat and timing for optimal biologic material thawing. BLFS also provides innovative cloud-connected evo shipping containers for the passive storage and secure transport of temperature-sensitive biologics and pharmaceuticals. Additionally, its comprehensive range encompasses liquid nitrogen laboratory freezers, various cryogenic equipment and accessories, and specialized storage services for biological and pharmaceutical products. Products are distributed both directly to customers and through a network of third-party distributors. Established in 1987, BioLife Solutions, Inc. maintains its headquarters in Bothell, Washington.

Key Executives

Name Position
Roderick de Greef Chief Executive Officer & Chairman
Sean Werner Chief Technology Officer
Troy Wichterman Chief Financial Officer
Aby J. Mathew Chairman of Scientific Advisory Board, Executive Vice President & Chief Scientific Officer
Todd Berard Chief Commercial Officer

Latest SEC Filings

Date Type Title
Sep 04, 2026 DEFM14A Filing
Aug 06, 2026 10-Q Quarterly Report
Aug 06, 2026 8-K Current Report
Aug 04, 2026 425 Filing
Aug 03, 2026 8-K Current Report
Jul 24, 2026 425 Filing
Jul 22, 2026 8-K Current Report
Jul 22, 2026 425 Filing
Jul 21, 2026 4 Filing
Jul 13, 2026 4 Filing
View All SEC Filings
BioLife Solutions Inc.
BioLife Solutions Inc. logo
Country United States
IPO Date Nov 21, 1989
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 155
CEO Roderick de Greef

Contact Details

3303 Monte Villa Parkway Bothell, Washington 98021 United States

Stock Details

Ticker Symbol BLFS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000834365
CUSIP Number 09062W204
ISIN Number US09062W2044
SIC Code 3845

© 2026 bestshares.com. All rights reserved.